FIELD: medicine. SUBSTANCE: method involves preparing leukocyte suspension in plasma, counting the leukocyte concentration and determining in series basal luminol-dependent and silicon dioxide-induced chemiluminescence leukocyte index. EFFECT: enhanced accuracy in diagnosing pathologic states of human organism and the degree of their severity.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF FORECASTING COURSE OF BRONCHIAL ASTHMA | 1991 |
|
RU2012884C1 |
METHOD TO EVALUATE STENOCARDIA DEGREE | 1992 |
|
RU2073869C1 |
METHOD FOR PREDICTING THE COURSE OF BRONCHIAL ASTHMA | 1992 |
|
RU2038599C1 |
METHOD FOR ESTABLISHING INDICATIONS FOR TREATMENT OF BRONCHIAL ASTHMA CASES | 1993 |
|
RU2088929C1 |
METHOD FOR PROGNOSTICATING SEVERITY OF DUODENAL ULCER COURSE | 0 |
|
SU1681252A1 |
METHOD OF CERTIFYING DRUGS | 1995 |
|
RU2124202C1 |
METHOD FOR PREDICTING INFECTED PANCREONECROSIS | 2006 |
|
RU2319150C1 |
METHOD OF TREATING SECONDARY MITOCHONDRIAL DYSFUNCTION IN CHILDREN SUFFERING URINOGENITAL PATHOLOGIES | 2014 |
|
RU2545907C1 |
METHOD FOR EVALUATING THE NATURE OF INFLAMMATION PROCESS IN PROSTATE | 2000 |
|
RU2174684C1 |
DIFFERENTIAL DIAGNOSTICS METHOD FOR DIAGNOSING HEMORRHAGIC VASCULITIS FORMS | 2003 |
|
RU2250464C1 |
Authors
Dates
1995-08-27—Published
1992-10-05—Filed